S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
3 Comeback Stocks to Buy in 2021
pixel
Stratasys Stock's Return from the Stratosphere Screams Buy
Arlo Technologies Stock is Turnaround Pullback Play
Senate vetting Biden's choice for SEC head amid stock drama
pixel
Stocks drift lower on Wall Street; yields continue to ease
Hertz eyes bankruptcy exit through $4.2 billion stake sale
Kohl's reports mixed 4Q results but offers upbeat outlook
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
3 Comeback Stocks to Buy in 2021
pixel
Stratasys Stock's Return from the Stratosphere Screams Buy
Arlo Technologies Stock is Turnaround Pullback Play
Senate vetting Biden's choice for SEC head amid stock drama
pixel
Stocks drift lower on Wall Street; yields continue to ease
Hertz eyes bankruptcy exit through $4.2 billion stake sale
Kohl's reports mixed 4Q results but offers upbeat outlook
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
3 Comeback Stocks to Buy in 2021
pixel
Stratasys Stock's Return from the Stratosphere Screams Buy
Arlo Technologies Stock is Turnaround Pullback Play
Senate vetting Biden's choice for SEC head amid stock drama
pixel
Stocks drift lower on Wall Street; yields continue to ease
Hertz eyes bankruptcy exit through $4.2 billion stake sale
Kohl's reports mixed 4Q results but offers upbeat outlook
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
3 Comeback Stocks to Buy in 2021
pixel
Stratasys Stock's Return from the Stratosphere Screams Buy
Arlo Technologies Stock is Turnaround Pullback Play
Senate vetting Biden's choice for SEC head amid stock drama
pixel
Stocks drift lower on Wall Street; yields continue to ease
Hertz eyes bankruptcy exit through $4.2 billion stake sale
Kohl's reports mixed 4Q results but offers upbeat outlook
pixel
Log in
NASDAQ:BLRX

BioLineRx Earnings Date, Estimates & History

$3.08
-0.08 (-2.53 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.05
Now: $3.08▼
$3.24
50-Day Range
$2.38
MA: $3.12▼
$4.00
52-Week Range
$1.06
Now: $3.08▼
$4.23
Volume540,095 shs
Average Volume2.76 million shs
Market Capitalization$120.29 million
P/E RatioN/A
Dividend YieldN/A
Beta2.08

Earnings

BioLineRx (NASDAQ:BLRX) Earnings Information

BioLineRx last released its quarterly earnings results on November 23rd, 2020. The biotechnology company reported ($0.30) EPS for the quarter, beating analysts' consensus estimates of ($0.36) by $0.06. BioLineRx has generated ($2.55) earnings per share over the last year. BioLineRx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 19th, 2021 based off prior year's report dates.

BioLineRx Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BioLineRx (NASDAQ:BLRX) Earnings Estimates

2021 EPS Consensus Estimate: ($0.62)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.16)($0.16)($0.16)
Q2 20211($0.16)($0.16)($0.16)
Q3 20211($0.15)($0.15)($0.15)
Q4 20211($0.15)($0.15)($0.15)

BioLineRx (NASDAQ BLRX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/19/2021
(Estimated)		       
11/23/20209/30/2020($0.36)($0.30)($0.30)Transcript
8/6/2020Q2 2020($0.60)($0.45)($0.45)N/A
5/20/2020Q1 2020($0.83)($0.60)($0.60)N/A
3/12/2020Q4 2019($0.64)($0.97)($0.97)Transcript
11/11/2019Q3 2019($0.67)($0.40)($0.40)N/A
8/6/2019Q2($0.65)($0.04)($0.04)N/A
5/14/20193/31/2019($0.05)($0.05)($0.05)N/A
3/28/201912/31/2018($0.09)($0.05)($0.05)N/A
11/8/20189/30/2018($0.06)($0.06)($0.06)N/A
8/13/2018Q2 2018($0.06)($0.05)($0.05)N/A
5/22/20183/31/2018($0.07)($0.06)($0.06)Transcript
3/6/2018Q4 2017($0.06)($0.07)($0.07)N/A
11/21/2017Q3 2017($0.05)($0.07)($0.07)N/A
8/8/20176/30/2017($0.05)($0.05)($0.05)$0.01 millionListen
5/25/20173/31/2017($0.05)($0.08)($0.08)$0.01 millionN/A
3/23/201712/31/2016($0.08)($0.13)($0.13)$0.02 millionN/A
11/22/2016Q316($0.07)($0.08)($0.08)N/A
8/11/2016Q216($0.07)($0.07)($0.07)Listen
5/17/2016Q116($0.08)($0.10)($0.10)Listen
3/10/2016Q415($0.06)($0.07)($0.07)Listen
11/16/2015Q315($0.08)($0.03)($0.03)Listen
8/20/2015Q215($0.10)($0.09)($0.09)Listen
5/18/2015Q115($0.10)($0.08)($0.08)Listen
4/13/2015Q4 2014($0.10)($0.11)($0.11)N/A
11/10/2014Q314($0.11)($0.02)($0.02)N/A
8/6/2014Q214($0.09)($0.12)($0.12)N/A
5/20/2014Q114($0.11)($0.01)($0.10)Transcript
3/17/2014Q4 2013($0.18)($0.20)($0.20)N/A
11/13/2013Q3 2013($0.18)($0.20)($0.20)N/A
8/6/2013Q2 2013($0.15)($0.20)($0.20)N/A
5/7/2013Q1 2013($0.02)($0.20)($0.20)Transcript
3/12/2013Q4 2012($0.29)($0.30)($0.30)N/A
11/14/2012Q312($0.15)Transcript
8/15/2012Q2 2012($0.25)($0.02)($0.02)N/A
5/15/2012Q1 2012($0.30)($0.30)N/A
3/22/2012Q4 2011($0.30)($0.30)N/A
11/29/2011Q3 2011($0.20)($0.20)N/A
8/23/2011Q2 2011($0.40)($0.40)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/3/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.